迁移性咽和颈段食管异物4例

目的：探讨迁移性咽和颈段食管异物的临床特征、诊断及治疗方法。方法：对位于腔壁内的异物，应尽量选用内镜下切开黏膜取出；若异物已移至腔外，则采用颈侧切开术。结果：4例患者均顺利取出异物，3例无并发症发生，1例声带麻痹。结论：颈部薄层CT扫描是证实异物迁移的重要手段，并对手术时定位异物有重要价值；食入异物出现迁移者，可产生致命性并发症，应及时处理。     

Factors related to sexual health in Chinese women with breast cancer in Hong Kong

Aim: To examine the association between a broad array of characteristics and sexuality in breast cancer patients in Hong Kong. Method: We collected data on demographic and clinical factors, psychosocial well‐being, quality of life (QOL), body image and sexual health of breast cancer patients presented to the Department of Clinical Oncology, Prince of Wales Hospital from November 2005 to February 2006. Results: More than 40% of Chinese breast cancer patients experienced moderate problems in sexual health. Their medical treatment had a greater influence on their sexual functioning in a change in their social activities, whereas more support from their partner predicted less influence. The presence of a child and more support from their partner predicted greater sexual satisfaction. Undergoing the menopause related to a longer time to resume sexual activity after cancer treatment. A change of relationship with their partner and a loss of self‐confidence were strong predictors of sexual problems influencing their QOL. Patients who had experienced a change in their relationship with their partner or had greater sexual problems were more likely to perceive greater benefit from professional intervention on sexual problem. Conclusion: An improvement in their intimate relationships and enhanced psychosocial functioning should improve the sexual health of Chinese women with breast cancer.     

FUNCTION OF THE HYPOTHALAMO-HYPOPHYSIAL-THYROID AXIS IN CHRONIC RENAL FAILURE

Hypothalamo-hypophysial-thyroid function has been studied in twenty-five patients with chronic renal failure. Eight were receiving conservative treatment, nine peritoneal dialysis and eight haemodialysis. All were clinically euthyroid. Total thyroxine (T4) and triiodothyronine (T3) levels were reduced but free T4 levels were normal, while free T3 was reduced in patients with the most severe renal failure. It is suggested that the binding of thyroid hormones by the transport proteins is reduced and that peripheral conversion of T4 to T3 is impaired in renal failure. The thyrotrophin response to thyrotrophin-releasing hormone (TRH) is reduced in renal failure but this reduction is probably independent of alterations in thyroid hormone metabolism. Growth hormone was released by TRH in seven of the patients studied, possibly as a result of protein malnutrition.     

Hand-assisted laparoscopic and open living donor nephrectomy in Korea

BACKGROUND: We compared the results of hand-assisted laparoscopic living donor nephrectomy (LLDN) and conventional open living donor nephrectomy (OLDN). METHODS: The clinical data on 49 hand-assisted LLDN and 21 OLDN on the left side performed at two institutions in Korea from January 2001 to February 2003 were reviewed. Demographic data of donors and recipients were similar in the two groups. RESULTS: There was one conversion to an open procedure due to bleeding in the LLDN group. The median operation times (180 min in LLDN versus 170 min in OLDN) and warm ischemic times (2.5 min in LLDN versus 2.0 min in OLDN) in the two groups were similar. The estimated mean blood loss, duration of hospital stay and complication rate was also similar in the two groups. The LLDN group reported less pain (visual analog scale) postoperatively (4.1 versus 5.3), but this was not significant (P=0.058). The time to oral intake in the LLDN group was significantly longer by an average of 1 day (P=0.001). Return to work was sooner in the LLDN group (4.0 weeks versus 6.0 weeks; P=0.026). The recipient graft function was equivalent between the two groups. Hand-assisted LLDN appears to be a safe and effective alternative to OLDN. CONCLUSION: Our findings suggest that this technique may give the ability provide grafts of similar quality to OLDN, while extending to the donors the advantages of a traditional LLDN procedure.     

Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms

Objectives: The aim of this study was to compare the efficacy of low (0.2 mg) and intermediate (0.4 mg) dose tamsulosin in treating lower urinary tract symptoms (LUTS). Methods: Patients were treated with low‐dose tamsulosin for an initial run‐in period of 12 weeks, then divided into two groups based on their clinical improvement. Patients were measured for objective parameters of peak flow rate and postvoid residual urine volume, as well as subjective symptom scores and perceived patient benefit of treatment. The items were then integrated as the LUTS Outcome Score to determine dose increase or maintenance. Overall outcome was determined at 36 weeks. Results: One hundred and seventy‐four patients were enrolled and started on 0.2 mg tamsulosin treatment. One hundred and fifty‐five patients completed the 36‐week study. Sixty patients required dose increase to 0.4 mg at the 12th week. Baseline characteristics showed that a patient who would benefit from 0.4 mg dosage had higher age, daytime frequency, and lower peak urine flow rate. Patients receiving both 0.2 and 0.04 mg both showed improved clinical outcome measures. Higher improvement was found in voiding component symptom scores and urine flow rate improvement in patients receiving an increased dose. Conclusion: Both low‐ and intermediate‐dose tamsulosin are effective treatment regimens. Increasing from low to intermediate dose should follow assessment of both objective and subjective improvements.     

EFFECT OF NIVAZOL ON ACTH SECRETION BY HUMAN PITUITARY CORTICOTROPHIC TUMOURS IN CELL CULTURE

The effects of nivazol, a novel steroid which lacks glucocorticoid activity, on ACTH secretion by cell cultures of human pituitary corticotrophic tumours has been investigated. Nivazol (0.002-20 mumol/l) inhibited ACTH secretion by 50-80%, after 4 and 24 h of incubation. (Trilostane (0.3-30 mumol/l) did not affect basal or stimulated ACTH secretion.) The potency of nivazol was comparable with that of hydrocortisone, and less than dexamethasone. The stimulatory effects of oCRF and AVP were reduced or completely blocked by nivazol in a similar manner to that previously described for hydrocortisone. It is concluded that nivazol may be of benefit in the direct treatment of Cushing's disease, particularly since it lacks glucocorticoid activity.     

Outcome of resuscitated apparently stillborn infants: A ten year review

This study addresses the dilemma of whether to attempt resuscitation of the previously undiagnosed fresh stillborn infant and evaluates factors predictive of survival and long-term outcome. We reviewed the clinical spectrum, immediate complications and long-term outcome of 45 successfully resuscitated apparently stillborn infants (34 term, 11 preterm) who were admitted to the Intensive Care Nursery. Significant obstetric and intrapartum events were identified in 34 (75%) infants while 11 (25%) had no apparent risk factors. Of the 39 infants with neonatal complications, 37 had hypoxic-ischaemic encephalopathy (HIE; Sarnat stage 1 in 5, stage 2 in 15, stage 3 in 17); 12 (27%) had oliguria, 10 (22%) had hypotension, 7 (16%) experienced hypoglycaemia, 4 (9%) had disseminated intravascular coagulopathy (DIC) and 1 (2%) had persistent pulmonary hypertension of the newborn (PPHN). Fourteen infants (31%) died in the neonatal period and four (9%) died during infancy. Risks of death and adverse neurodevelopment were significantly increased in infants with stage 2 or 3 HIE ( P <0.005). Follow-up assessment of 24 of the 27 surviving infants revealed a normal outcome in 15 (63%), severe disability in six (25%), moderate disability in two (8%) and mild disability in one (4%) infant. The positive predictive value of stage 2 or 3 HIE was 70% for mortality and 80% for morbidity. One-third (15/45) of successfully resuscitated apparently stillborn infants were normal at follow-up assessment and the outcome for these infants was predicted with complete accuracy by the stage of HIE present during the neonatal period.     

FENTANYL AND THE {beta}-ENDORPHIN, ACTH AND GLUCOREGULATORY HORMONAL RESPONSE TO SURGERY

The effect of the supplementation of nitrous oxide—oxygenanaesthesia with either fentanyl 15 µg kg^–1 or 0.5%halothane on the ß-endorphin, ACTH, glucoregulatoryhormonal and metabolic response to pelvic surgery was investigated.Fentanyl inhibited the increases in circulating ß-endorphin,ACTH, growth hormone, cortisol and glucose concentrations foundin the patients receiving halothane. Changes in circulatingß-endorphin concentrations during surgery probablyreflect alterations in pituitary secretion and appear to haveno major metabolic effects. The suppression of pituitary secretionpersisted for at least 4 h after the start of surgery.